NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called Medicare GLP-1 Bridge. [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know | 5 | 5 | 01-07-2026 |
| 2 | GLP-1 use hits record high as Medicare opens access to weight-loss drugs | 0 | 7 | 09-07-2026 |
| 3 | GLP-1 insurance change impacts millions of Americans: What to know, how to tell if you’re covered | 0 | 7 | 18-07-2026 |
| 4 | CMS’ GLP-1 Bridge Demonstration | 0 | 8.21 | 24-06-2026 |
| 5 | Novo Nordisk’s obesity drug Wegovy gets CDSCO approval to treat liver condition | 5 | 7 | 17-07-2026 |
| 6 | GLP-1s are changing US healthcare, should everyone be on them? | 0 | 8.04 | 25-07-2026 |
| 7 | Women more often hired after losing weight on GLP-1s: Study | 0 | 5 | 03-07-2026 |
| 8 | Medicare prescriptions for Wegovy jumped after approval for heart disease | 0 | 7 | 09-07-2026 |
| 9 | GLP-1 drugs could reduce long-term sick leave: Study | 0 | 18.9 | 26-07-2026 |
| 10 | GLP-1 drugs could reduce long-term sick leave: Study | 0 | 18.9 | 26-07-2026 |